| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EXPNEUROL.2009.11.019 |
| P8608 | Fatcat ID | release_plwxpje4tbgrxj5khldff2sy6u |
| P698 | PubMed publication ID | 19961850 |
| P50 | author | Frauke Zipp | Q21259942 |
| P2093 | author name string | Josephine Herz | |
| Volker Siffrin | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 9-17 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Neurodegeneration in autoimmune CNS inflammation | |
| P478 | volume | 225 |
| Q35935083 | Aggregation of MBP in chronic demyelination |
| Q39377291 | Altered expression of CXCR3 and CCR6 and their ligands in HTLV-1 carriers and HAM/TSP patients |
| Q57474921 | Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study |
| Q38071242 | Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models |
| Q34094705 | Bushen Yisui Capsule ameliorates axonal injury in experimental autoimmune encephalomyelitis. |
| Q35834510 | CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity |
| Q36089786 | Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis. |
| Q35675723 | Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination |
| Q38446276 | Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis |
| Q37229746 | Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties |
| Q57808694 | Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients |
| Q35937668 | Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis |
| Q33862545 | Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis |
| Q34580168 | EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE) |
| Q36492329 | Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis |
| Q44516794 | Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect |
| Q34472020 | Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein |
| Q39259539 | Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination. |
| Q37224656 | Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. |
| Q48060946 | In silico and In vitro evaluation of the anti-inflammatory potential of Centratherum punctatum Cass-A. |
| Q36590210 | Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death |
| Q36319914 | Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages |
| Q48186044 | Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis |
| Q41854924 | Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis |
| Q91699174 | Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis |
| Q91338016 | Nav1.5 in astrocytes plays a sex-specific role in clinical outcomes in a mouse model of multiple sclerosis |
| Q31044261 | Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). |
| Q38863014 | Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats |
| Q27023974 | Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration |
| Q37619291 | No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis |
| Q36845177 | Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis |
| Q30238775 | Overview of Traumatic Brain Injury: An Immunological Context |
| Q37530805 | PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases |
| Q90401297 | Protective and Regenerative Roles of T Cells in Central Nervous System Disorders |
| Q35109615 | Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation |
| Q90211737 | Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation |
| Q26786915 | Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems |
| Q48126920 | Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation |
| Q28728862 | Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice |
| Q92403166 | The Bu Shen Yi Sui Formula Promotes Axonal Regeneration via Regulating the Neurotrophic Factor BDNF/TrkB and the Downstream PI3K/Akt Signaling Pathway |
| Q33698702 | The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis |
| Q34982119 | The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry |
| Q48104255 | The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis |
| Q36332494 | Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant |
| Q38020092 | Will the real multiple sclerosis please stand up? |
Search more.